Description: - A unique collection of 524 neuroregeneration related compounds for high throughput and high content screening;- Targets several signaling pathways, such as Notch, MAPK, Wnt/β-catenin, mTOR, etc.;- Bioactivity and safety confirmed by pre-clinical research and clinical trials, and some of them are approved by FDA;- Detailed compound information with structure, target, activity, IC50 value, and biological activity description;- tructurally diverse, medicinally active, and cell permeable;- NMR and HPLC validated to ensure high purity and quality;